#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Langerhans' cell histiocytosis Plasma cell myeloma Cutaneous calcification Blood iron increased Cerebral arteriovenous malformation haemorrhagic Barth syndrome Systemic scleroderma Systemic sclerosis pulmonary Oesophageal adenocarcinoma stage III Albright's disease Primary amyloidosis Extra-osseous Ewing's sarcoma Immune-mediated myositis Vascular calcification Leukaemia More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis – Diagnostics Arterial tortuosity syndrome – Diagnostics Mucopolysaccharidosis II – Diagnostics Pulmonary fibrosis – Trials in Disease Turner’s syndrome – Treatment Congenital generalised lipodystrophy – Life with Disease Medulloblastoma – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Ewing’s sarcoma metastatic – Treatment Noonan syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sapablursen Tolu Balsam ANHYDROUS CALCIUM FOLINATE Prx005 Apl-101 Clobetasol Metamizole Sodium Monohydrate Fluorouracil Oxygen Tafasitamab Ketoprofen Lysine IPN01195 Olorofim Midazolam Hydrochloride Mebeverine Hydrochloride Choriogonadotropin Alfa Trastuzumab Deruxtecan Lutikizumab Bi 706321 Magrolimab More therapies…

    Learn about Your Condition

    Ejection fraction normal Arginase deficiency Hypertrophic scar Astrocytoma malignant Wheezing Oral neoplasm Ependymoma Gastrointestinal carcinoma Urethral valves Diarrhoea BRAF gene mutation Foetal growth restriction Obesity Ectopic pregnancy Psoriasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Mepolizumab
    • Benralizumab
    • Depemokimab
    Austria Finland France Germany Ireland Italy +6

  • Study on Benralizumab for Patients with Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Benralizumab
    France

  • Study on the Effects of ARO-RAGE (ADS-015) for Patients with Inflammatory Lung Disease

    Not recruiting

    1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Ads-015
    Poland Spain

  • Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Dupilumab
    Belgium Bulgaria Greece Hungary Ireland Romania +1

  • Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Atuliflapon
    • Salbutamol
    Bulgaria Croatia Germany Hungary The Netherlands Poland +4

  • Study on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tezepelumab
    Czechia Poland
Previous Page
1 … 10 11 12 13 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!